AU2017235901A1
|
|
scFv antibodies which pass epithelial and/or endothelial layers
|
AU2016273957A1
|
|
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFa
|
AU2016253633A1
|
|
Functionalized polypeptides
|
AU2016222411A1
|
|
Methods for identifying immunobinders of cell-surface antigens
|
AU2016204739A1
|
|
Stable and soluble antibodies inhibiting TNFalpha
|
AU2016200367A1
|
|
scFv antibodies which pass epithelial and/or endothelial layers
|
AU2015201794A1
|
|
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFa
|
AU2014262201A1
|
|
Method for decreasing immunogenicity
|
AU2013207650B2
|
|
Stable and soluble antibodies inhibiting TNFalpha
|
AU2013203477A1
|
|
Solubility optimization of immunobinders
|
AU2013203478A1
|
|
Methods for identifying immunobinders of cell-surface antigens
|
AU2013203533A1
|
|
scFv antibodies which pass epithelial and/or endothelial layers
|
AU2013202997A1
|
|
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFalpha
|
AU2011265593A1
|
|
Stable and soluble antibodies inhibiting TNFalpha
|
TW201630623A
|
|
Stable and soluble antibody
|
AU2009270405A1
|
|
Functionalized polypeptides
|
AU2003237650A1
|
|
A method for identifying protein-protein interactions
|